Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Dihydromyricetin has demonstrated promising effects in glycemic control, insulin sensitivity
and insulin secretion, that above mentioned findings show that dihydromyricetin has an
excellent potential effect in the treatment of type 2 diabetes mellitus patients.